• De novo assembly, BLAST and genome finishing with QIAGEN CLC Genomics Workbench

    Virtual - Americas - EST , United States

    Description This webinar will introduce users to the tools available for short reads (Illumina) as well as long reads (Oxford Nanopore, Pac Bio) de novo assembly in CLC Genomics Workbench. It will also go over other useful functionalities such as BLAST and genome finishing.   Participants will learn the following:   o Download and install […]

  • De novo assembly, BLAST and genome finishing with QIAGEN CLC Genomics Workbench

    HSMD-screen-grab-2

    Description This webinar will introduce users to the tools available for short reads (Illumina) as well as long reads (Oxford Nanopore, Pac Bio) de novo assembly in CLC Genomics Workbench. It will also go over other useful functionalities such as BLAST and genome finishing.   Participants will learn the following:   o Download and install […]

  • Antimicrobial resistance (AMR) and multi-locus sequence typing (MLST) with QIAGEN CLC Genomics Workbench

    Virtual - Americas - EST , United States

    You asked for it by popular demand, and we’re here to deliver. In this training, we’ll cover how antimicrobial resistance (AMR) is used for isolation or can be easily integrated with other functionalities such as multi-locus sequence typing (MLST). In this training, we’ll cover: Introduction to AMR, MLST and relevant databases QIAGEN Microbial Insight - […]

  • Antimicrobial resistance (AMR) and multi-locus sequence typing (MLST) with QIAGEN CLC Genomics Workbench

    HSMD-screen-grab-2

    You asked for it by popular demand, and we’re here to deliver. In this training, we’ll cover how antimicrobial resistance (AMR) is used for isolation or can be easily integrated with other functionalities such as multi-locus sequence typing (MLST). In this training, we’ll cover: Introduction to AMR, MLST and relevant databases QIAGEN Microbial Insight - […]

  • Assessing drug safety with QIAGEN Biomedical KB-AI

    Virtual - Americas - EST , United States

    Are you a healthcare professional, clinical researcher or data scientist interested in drug safety research? If so, you know how vital understanding a drug’s adverse effects is to maximize its effect while minimizing its risks. This webinar will show how the QIAGEN Biomedical KB-AI knowledge graph can be used to explore scientific and pharmacovigilance data. […]

  • Assessing drug safety with QIAGEN Biomedical KB-AI

    HSMD-screen-grab-2

    Are you a healthcare professional, clinical researcher or data scientist interested in drug safety research? If so, you know how vital understanding a drug’s adverse effects is to maximize its effect while minimizing its risks. This webinar will show how the QIAGEN Biomedical KB-AI knowledge graph can be used to explore scientific and pharmacovigilance data. […]

  • Checkpoint inhibitor and immuno-oncology investigation through OmicSoft Lands APIs

    Virtual - Americas - EST , United States

    While there is great interest in the scientific community to investigate drug targets and biomarkers from public immune-oncology data, such investigation is hindered by the difficulty in finding and combining related datasets to perform large-scale meta-analyses. This webinar will focus on how high quality curated genomic repositories such as the QIAGEN OmicSoft Lands database immediately […]

  • IPA deep dive: miRNA investigation using QIAGEN Ingenuity Pathway Analysis (IPA)

    Virtual - Americas - EST , United States

    In this 90-minute training session, you will learn how to identify target mRNAs for your miRNAs of interest and associate them with pathways, diseases, biological functions, tissues and cell types. Topics that will be covered include: How to analyze miRNA-seq datasets alone or both miRNA and corresponding mRNA datasets together How to use QIAGEN IPA […]

  • Checkpoint inhibitor and immuno-oncology investigation through OmicSoft Lands APIs

    HSMD-screen-grab-2

    While there is great interest in the scientific community to investigate drug targets and biomarkers from public immune-oncology data, such investigation is hindered by the difficulty in finding and combining related datasets to perform large-scale meta-analyses. This webinar will focus on how high quality curated genomic repositories such as the QIAGEN OmicSoft Lands database immediately […]

  • Probing OncoLand using OmicSoft Studio

    Virtual - Americas - EST , United States

    There's more than one way to probe our OncoLand data. With the OmicSoft Studio graphical user interface (GUI), you won't need a script to fetch the data you want. This training will show how high-quality curated genomic repositories, such as the QIAGEN OmicSoft Lands, immediately allow in-depth investigations across diverse oncology and normal tissues/cells data […]

  • Probing OncoLand using OmicSoft Studio

    HSMD-screen-grab-2

    There's more than one way to probe our OncoLand data. With the OmicSoft Studio graphical user interface (GUI), you won't need a script to fetch the data you want. This training will show how high-quality curated genomic repositories, such as the QIAGEN OmicSoft Lands, immediately allow in-depth investigations across diverse oncology and normal tissues/cells data […]

  • Discovery from sample-level public data (GEO, SRA and more) using IPA Land Explorer

    Virtual - Americas - EST , United States

    Within QIAGEN Ingenuity Pathway Analysis (IPA), public data sourced from OmicSoft is already processed and standardized, making it easy to jump to the actual research. In this training, we'll show how to effectively use sample-level public data and metadata from sources like GEO, SRA, TCGA, GTEx, Blueprint, CCLE and other sources using the IPA Analysis […]